youtube_live
Q3 2026 earnings • released • EPS beat +496.65% • Revenue miss -3.22%
See resultschevron_right
CNC:NYSE
Centene Corp
$68.45
arrow_downward
-0.25%(-0.17) 1D
$68.89
arrow_upward
+0.64% (+0.44)bedtimeAfter hours
Closed: Oct 30, 3:00:05 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CNC...
Open
$69.31
High
$70.17
Low
$66.82
Mkt. cap
33.89B
Avg. vol.
4.94M
Volume
4.81M
P/E ratio
23.46
52-wk high
$72.50
52-wk low
$31.63
EPS
$2.92
Beta
1.13
Shares outstanding
495.07M
No. of employees
61K
Open
$69.31
High
$70.17
Low
$66.82
Mkt. cap
33.89B
Avg. vol.
4.94M
Volume
4.81M
P/E ratio
23.46
52-wk high
$72.50
52-wk low
$31.63
EPS
$2.92
Beta
1.13
Shares outstanding
495.07M
No. of employees
61K
News stories
From web sources and news partners
News Corp
·
1 hour ago
Investors Are Betting a Blue Wave Will Help Hospitals. Don’t Count on It.
Yahoo Finance
·
2 days ago
Centene Corporation (CNC) Stock Forecasts
Profile
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500. Wikipedia
About Centene Corp
CEOSarah M. London
Employees61.1K
Founded1984
HeadquartersSt. Louis, Missouri, United States
SectorHealth care provider
Websitecentene.com
Analyst ratings
Based on 14 analysts giving stock ratings to CNC in the past 3 months
Buy
Buy
5
Hold
9
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CNC in the last 3 months.
Highest
Current $68.45
$82.00 (+19.80%)
Average
$75.38 (+10.12%)
Lowest
$65.00 (-5.04%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
John Stansel J.P. Morgan | Hold | Maintained | $75.00 | +9.6% | 10/29/2026 |
Ryan Langston TD Cowen | Hold | Maintained | $65.00 | -5% | 10/29/2026 |
Andrew Mok CFA Barclays | Buy | Maintained | $82.00 | +19.8% | 10/28/2026 |
A.J. Rice UBS | Hold | Reiterated | $78.00 | +14% | 10/28/2026 |
Sarah James Cantor Fitzgerald | Buy | Reiterated | $79.00 | +15.4% | 10/27/2026 |
Ann Hynes Mizuho Securities | Hold | Maintained | $72.00 | +5.2% | 10/28/2026 |
Michael Ha Robert W. Baird | Hold | Maintained | $71.00 | +3.7% | 10/28/2026 |
Stephen Baxter Wells Fargo | Hold | Reiterated | $75.00 | +9.6% | 10/30/2026 |
Erin Wright Morgan Stanley | Hold | Reiterated | $71.00 | +3.7% | 10/28/2026 |
Kevin Fischbeck Bank of America Securities | Buy | Reiterated | $82.00 | +19.8% | 10/27/2026 |
Jason Cassorla Guggenheim | Hold | Maintained | - | - | 10/27/2026 |
Ben Hendrix RBC Capital | Hold | Maintained | $71.00 | +3.7% | 10/07/2026 |
Lance Wilkes Bernstein | Buy | Maintained | $79.00 | +15.4% | 10/05/2026 |
John Staszak Argus Research | Buy | Upgraded | $80.00 | +16.9% | 08/10/2026 |
David S Macdonald Truist Financial | Buy | Reiterated | $80.00 | +16.9% | 07/29/2026 |
Joanna Gajuk Bank of America Securities | Buy | Maintained | $74.00 | +8.1% | 07/17/2026 |
George Hill Deutsche Bank | Buy | Upgraded | $80.00 | +16.9% | 05/20/2026 |
Scott Fidel Goldman Sachs | Sell | Maintained | $40.00 | -41.6% | 04/29/2026 |
Michael Wiederhorn Oppenheimer | Buy | Reiterated | $58.00 | -15.3% | 04/29/2026 |
David Windley Jefferies | Hold | Maintained | $39.00 | -43% | 04/20/2026 |
Last report
Oct 27, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.58 / $0.10
+496.65%beat
arrow_upward
Revenue / Est. (USD)
45.44B / 46.95B
-3.22%miss
arrow_downward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 45.09B | 45.06B | 44.82B | 45.44B |
Cost of goods sold | 41.49B | 38.30B | 39.03B | 41.13B |
Cost of revenue | 41.49B | 38.30B | 39.03B | 41.13B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 3.35B | 3.38B | 3.05B | 2.92B |
Operating expense | 4.45B | 4.48B | 4.10B | 3.97B |
Total operating expenses | 45.94B | 42.78B | 43.12B | 45.10B |
Operating income | -847.00M | 2.28B | 1.70B | 337.00M |
Other non operating income | - | - | - | - |
EBT including unusual items | -1.54B | 2.10B | 1.49B | -122.00M |
EBT excluding unusual items | -1.02B | 2.12B | 1.55B | 188.00M |
Income tax expense | -443.00M | 560.00M | 399.00M | -57.00M |
Effective tax rate | 28.71% | 26.68% | 26.85% | 46.72% |
Other operating expenses | 771.00M | 794.00M | 745.00M | 750.00M |
Net income | -1.10B | 1.54B | 1.09B | -71.00M |
Net profit margin | -2.44% | 3.42% | 2.43% | -0.16% |
Earnings per share | -1.19 | 3.37 | 2.51 | 0.58 |
Interest and investment income | - | - | - | - |
Interest expense | -168.00M | -164.00M | -153.00M | -149.00M |
Net interest expenses | -168.00M | -164.00M | -153.00M | -149.00M |
Depreciation and amortization charges | 160.00M | 134.00M | 139.00M | 138.00M |
EBITDA | -518.00M | 2.58B | 2.00B | 636.00M |
Gain or loss from assets sale | 501.00M | - | - | 15.00M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events